Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Phase I/II pharmacokinetic and safety data reported at AAD for Atrisone

March 8, 2001

Phase Ib trial of RK-0202 for oral mucositis to commence shortly

March 8, 2001

Cellegy seeks marketing approval for Rectogesic in South Korea

March 8, 2001

Favorable data presented this week for subcutaneous anti-CD11a antibody product for psoriasis

March 7, 2001

Switch Biotech and TUM enter research alliance on atopic dermatitis

March 7, 2001

Biogen's disease-modifying psoriasis therapy maintains efficacy upon retreatment

March 7, 2001

Positive phase III results announced for Metvix PDTas treatment of actinic keratosis

March 7, 2001

Phase IIa trial results presented at AAD meeting for ABX-IL-8 in psoriasis

March 6, 2001

AAD news: antipsoriatic activity of low-dose Ontak confirmed in pilot trial

March 6, 2001

Sustained clinical activity reported in IDEC-114 phase I/II trial for psoriasis

March 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...